UnknownPhase 3NCT04008316
Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis
Studying Immunoglobulin A vasculitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Evangeline PILLEBOUT, MDAPHP
- Intervention
- Colchicine(drug)
- Enrollment
- 264 enrolled
- Eligibility
- 18-85 years · All sexes
- Timeline
- 2019 – 2023
Study locations (1)
- Saint Louis Hospital, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04008316 on ClinicalTrials.govOther trials for Immunoglobulin A vasculitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07315191Finerenone Therapy for Pediatric HSPN With Mild ProteinuriaCapital Institute of Pediatrics, China
- RECRUITINGNANCT05951517Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein PurpuraSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- ACTIVE NOT RECRUITINGPHASE3NCT05329090Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA VasculitisHopital Foch
- RECRUITINGNANCT03647852Clinical Study on Strategy for Refractory Henoch-Schönlein PurpuraChildren's Hospital of Fudan University